ABSTRACT
Introduction
Postoperative hoarseness is one of the laryngopharyngeal complaints or discomforts. Hoarseness after double lumen tube intubation is considered a frequent hazard after general endotracheal anesthesia, ranging between 21% and 65%.
(1) In modern surgical practice, patients are observed postoperatively as many anesthesia induced complications may occur in the postoperative recovery room period. Minor hazards associated with anesthesia could occur during the first postoperative days. Postoperative hoarseness is an unfavorable side effect, limiting patient's activity and reducing his satisfaction.
(2)
Knoll et al. demonstrated that postoperative hoarseness occurred more commonly using double lumen tube than using a simple endotracheal tube.
(3) Up to recently, there were no enough strong measures to decrease the incidence of postoperative hoarseness especially after using bronchocath.
(4) Dexamethasone is used in the management of conditions induced by tracheal mechanical irritation due to its modulating potency of tissue edema. Preventive use of dexamethasone can decrease the incidence of post-tracheal extubation airway obstruction due to laryngeal edema.
(6)
Hoarseness is an abnormal deep, harsh voice triggered by a various states. It is initiated by irritation or injury to the vocal cords. The most frequent cause is acute laryngitis. Other causes include: benign vocal cord masses, gastro esophageal reflux, allergy, inhalation of irritants, thyroid conditions, trauma to the vocal cords or larynx, neurological conditions and cancer of the larynx. Hoarseness is one of the most frequent postoperative manifestations after tracheal extubation, (1) and the implications differ according to duration, regarding factors causing it and intensity of traumatic laryngeal injury. This clinical manifestation is temporary, and lasts mainly 2-3 days. In 10% of cases, it becomes permanent.
(1) Preventive steroid therapy to decrease the frequency of postextubation hoarseness is controversial. Only a very few number of studies involve adults especially with a double lumen endobronchial tube.
The objective of our investigation was to assess the role of preventive pre-induction dexamethasone with laryngoscopic CormackLehane scoring system in predicting the incidence of hoarseness post-tracheal extubation in patients undergoing video-assisted thoracoscopic surgery.
Methods
This is a retrospective review of review of 105 subjects, of both gender, aged 15-85 years, ASA class I-II who were scheduled for video-assisted thoracoscopic surgery for various indications during the period from January 2010 to March 2011 (Table I) . Written informed consent from all participants and approval from the ethics committee of the Royal Medical Services was obtained. Any subject with previous hoarseness was ruled out from the investigation (exclusion criteria). Preoperatively, all subjects were divided in a random manner using sealed envelopes method, into two groups. Group I (n=52) received 16mg (4ml) intravenous dexamethasone and group II (n=53) received 8mg (2ml) intravenous dexamethasone (Medochemie ltd, Limassol, Cyprus-EU-) and 2ml normal saline 0.9%. General anesthesia was induced using fentanyl 3cg/kg, propofol 2mg/kg and cisatracurium 0.15mg/kg. Direct laryngoscopy was done and glottic view was assessed by an anesthesiologist using modified Cormack-Lehane system score (mCMLS score) In our study, group Ia (n=49) included patients with mCMLS score I, IIA and IIB, group Ib (n=3) included patients with mCMLS score III and IV, group IIa(n=50) included patients with mCMLS score I,IIA and IIB and group IIb (n=3) included patients with mCMLS score III and IV (Table II) . Disposable polyvinyl chloride bronchocath tube (left sided, Mallinckrodt, Ireland) size 35 FG and 37 FG was inserted in female and male patients, respectively. Through bronchocath, all patients received O2 1L/min and isoflurane concentration of 1-2% which was needed to maintain anesthesia along with incremental doses of cisatracurium 0.03 mg/kg. Monitoring consisted of ECG, SpO2, EtCO2 and NIBP.Ten minutes before wound closure, all subjects received intravenous morphine 5 mg. Residual muscle relaxant was reversed using neostigmine and atropine. Extubation of bronchocath was performed in all patients when ventilation was adequate. The pressure inside the double lumen cuff was not measured.
Intraoperative evaluation glottic view as determined by laryngoscopic Cormack-Lehane system score was recorded in addition to time of achieving intubation (from laryngoscopy up to intubation) and number of intubation trials. Postoperative evaluation at two, 30 and 48 hours intervals was done. All subjects were observed for hoarseness (a laryngopharyngeal discomfort) which is a change in voice quality. Chi-square was used to compare discrepancies in gender, smoking habit and hoarseness postbronchocath extubation. P value less than 0.05 was taken as significant. Values in our investigation were taken as mean +/-SD, number, percentage or range.
Results
There were no significant differences between subgroups GIa, GIIa and GIb, GIIb in terms of number, gender, smoking habit, age, weight and ASA.P>0.05. The initial study included 108 subjects, of whom three were excluded out before the start of the study due to previous history of hoarseness for various causes (Table  II) . There were no significant differences regarding CMLS score, intubation time and intubation trials between GIa, GIIa and GIb, GIIb.P>0.05 (Table III) . Lung biopsy was the first indication for VATS in our study (40%), followed by pleural biopsy (13%) and third, mediastinal mass biopsy (10%). The frequency of postoperative hoarseness increased from two hour interval up to 30h interval in all groups. In GIa, it increased from 2.04% to 12.2% and in GIb, it increased from 33.3% to 66.7% (Table IV) . These figures began to decrease at 48 hour intervals, as it became: 0% in GIa and 0% in GIb. Regarding the percentage of hoarseness and mCMLS score, there was one case of IIB in GIa and one case of IV in GIb, at two hour interval. At 30h interval, there were one case of I plus two cases of IIA plus three cases of IIB in GIa and one case of III and finally one case of IV in GIb. At 48 hour interval, there were no cases of hoarseness in GIa and GIb. There were 9 cases of hoarseness at two hour postoperative interval, 26 cases of hoarseness at 30 hour interval and 4 cases of hoarseness at 48 hour interval while at 72 hour interval all patients were symptom free. Of the 9 patients at 2 hour interval, eight were females, of 26 patients at 30 hour interval, 20 were females and of 4 patients at 48 hour interval, 2 were females. At 2 hour interval, 4 patients were female smokers, at 30 hour interval, 12 patients were female smokers and at 48 hour interval, 2 patients were female smokers. All patients with hoarseness were in the 15-40 year age group as 10 patients were in GIa, one patient was in GIb (P<0.05). In GIb, 2 of 3 patients had hoarseness. In GIa, 6 of 49 patients had hoarseness (P<0.05).
Discussion
Our results demonstrated that preinduction administration of 16mg Dexamethasone intravenously, reduced the frequency of postoperative hoarseness at two and 30 hours intervals post-tracheal extubation, in comparison to 8mg Dexamethasone given in similar fashion. Injuries to the airway are well known complications of anesthesia and claims for airway injuries are common in the ASA closed claims, where the most frequent site of injuries to the airway is the larynx, reaching 33% of all airway injuries claims. Hoarseness is a frequent postoperative complication which affects patient satisfaction and activity even after leaving the hospital. In the past, several risk factors for postoperative hoarseness were recognized, including ETT size, cuff design and pressure as well as demographic factors such as gender or even the type of surgery.
(6) In our investigation, we limited type of surgery to only video assisted thoracoscopic surgery which did not exceed 2 hours maximum.
(2)
Postoperative hoarseness during general anesthesia is an important cause of morbidity for patients and a cause of liability. Various risk factors of laryngeal injury have been recognized. In the past, however, whether the quality of double lumen endotracheal tube affects its frequency or intensity is still unclear.
(1)
Bronchocath is inserted to maintain one lung anesthesia for lung isolation, one lung ventilation, bronchopulmonary alveolar lavage and lung collapse. Enhancement of thoracoscopic approaches has permitted more inventive methods for biopsy, lung resection, lung reduction surgery, pleurectomy and sympathectomy. The insertion and manipulation of bronchocath can induce trauma to the airway due to their increased irritation contact with pharyngeal, laryngeal and tracheal surfaces. Postoperative hoarseness is one of the laryngopharyngeal complaints or discomforts. Jones et al. showed that the mean duration of postoperative hoarseness was 16+/-11 hours. 
Knoll et al.
(3) demonstrated that the highest incidence of hoarseness post bronchocath extubation was at 24 hour intervals after which it was absent at 72 hours and more. In our investigation, the frequency of postoperative hoarseness increased from two to 30 hours. We assume that the structural injuries of vocal cords induced by bronchocath and stop of residual actions of anesthetics and opiates 30 hour post bronchocath extubation have caused this. Hoarseness must not be confused with sore throat as it is almost always accompanied by endotracheal intubation and is induced mainly by lengthened abduction of and pressure on the vocal cords.
(9) Traumatic endotracheal intubation can induce direct trauma to the vocal cords causing prolonged hoarseness. (6) The mechanism involved could be its anti-inflammatory action with depression of leukocyte migration, maintenance of cell membrane integrity, inhibition of lysosome release and decrease of fibroblast proliferation. (10) Knoll et al. showed that the majority of vocal cord injuries after bronchocath insertion were accompanied by redness and edema.
(3) Sang Hyun Park et al. demonstrated that the frequency of post-tracheal extubation hoarseness was 11% and 4% at one postoperative hour in patients administered 0.1 and 0.2mg dexamethasone, respectively. Postextubation hoarseness incidence at 24 postoperative hours was 31% and 15% in our respective patients, who were classified as Cormack-Lehane I and II.
(11) Several clinical studies have described postoperative hoarseness after general aneathesia. In many of these, hoarseness was caused by the high pressure of the endotracheal tube cuff as excessive pressure produces ischemia of the tracheal mucosa. However, within the safe pressure limits, postoperative hoarseness was still often noticed.
In our study, we did not monitor the intracuff pressure; instead the cuff leak was followed up. In our investigation, we think that movement of the tube in the trachea was found to be related with an increased frequency of hoarseness as it is needed to change from double to single lumon and to change position of a patient from supine to lateral, therefore moving the tube inside the trachea, though this was not included in our study. The potential advantage of steroids is based on its anti-inflammatory actions which inhibit the release of inflammatory mediators and reduce capillary permeability. The risk of harm from steroid therapy for 24 hours or less is negligible. The choice of dexamethasone was based on its negligible mineralocorticoid effects and long duration of action. Our investigation had two limitations. First, it included a small patient sample size and second, the follow up was for only 72 hours, although all patients were symptom free. In our study, we noticed that there were some risk factors, for instance: at two hour postoperative interval there were 8 females (88.9%) of total of 9 who experienced hoarseness. At 30 hour postoperative interval there were 20 females (76.9%) of total of 26 who had hoarseness and at 48 hours postoperative interval there were 2 females (50%) of a total of four with hoarseness, with a decreasing percentage in comparison with males in postoperative time. Female mucous membranes are less resistant to trauma and thinner than those in men. The total frequency of hoarseness was 9 at two hour interval, increased to 26 at 30 hour interval then decreased to four at 48 hour interval. After 72 hours, all patients were free from this symptom. There was no difference between patients with hoarseness in terms of smoking, as four of nien were female smokers at two hours interval, 12 of 26 were female smokers at 30 hour interval and two of four were female smokers at 48 hour interval. All subjects with hoarseness were in the 15-40 years age group. Regarding CMLS score and hoarseness, we found that 100% of patients in GIIb had hoarseness compared to 66% in GIa. In the same group, 30% of patients in GIIa had hoarseness compared to 12% in GIa. In our opinion, risk factors of postoperative bronchocath extubation hoarseness were Cormack-Lehane score III and IV, female gender and age group 15-40 years.
Conclusion
A single preventive preinduction intravenous administration of 16mg Dexamethasone in patients with laryngoscopic Cormack-Lehane score I, IIA and IIB are good predictors of a low frequency of hoarseness post-bronchocath extubation in subjects undergoing video-assisted thoracoscopic surgery.
